Literature DB >> 7576131

A subset of patients with recurrent spontaneous abortion is deficient in transforming growth factor beta-2-producing "suppressor cells" in uterine tissue near the placental attachment site.

R G Lea1, J Underwood, K C Flanders, H Hirte, D Banwatt, S Finotto, I Ohno, S Daya, C Harley, M Michel.   

Abstract

PROBLEM: To determine if patients with unexplained recurrent miscarriage have a deficiency of decidual immunosuppressor cells that produce transforming growth factor beta type 2, as has been found in mice with abortion due to rejection and/or trophoblast failure.
METHODS: Decidual biopsy specimens were taken as near to the placental attachment site as possible under ultrasound guidance from first trimester legal termination (control) patients with recurrent miscarriage and non-viable pregnancy, and from patients with sporadic missed abortion. The tissue was tested for TGF beta-2+ suppressor cells by in situ hybridization, immunohistochemistry, and analysis of supernatants.
RESULTS: TGF beta-2-related suppressor molecules similar but not identical to those identified in pregnant mice were released by decidual lymphoid cells. Fifty percent of 14 recurrent miscarriage patients showed a lack of suppressor cells and 59% were subnormal in comparison to 20 controls and 5 sporadic miscarriage patients, where 80-85% of the patients had detectable suppressor cells.
CONCLUSIONS: Suppressor cell deficiency is compatible with a role for rejection and/or trophoblast failure in some patients with recurrent miscarriage. Presence of suppressor cells in most patients with missed abortion (4/5) is compatible with an alternative cause of fetal death, similar to findings reported in genetic fetal death mice.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7576131     DOI: 10.1111/j.1600-0897.1995.tb00919.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  9 in total

1.  Correlation of NK cell activation and inhibition markers with NK cytoxicity among women experiencing immunologic implantation failure after in vitro fertilization and embryo transfer.

Authors:  Carolyn B Coulam; Roumen G Roussev
Journal:  J Assist Reprod Genet       Date:  2003-02       Impact factor: 3.412

2.  Suppressed cell-mediated immunity and monocyte and natural killer cell activity following allogeneic immunization of women with spontaneous recurrent abortion.

Authors:  U Gafter; B Sredni; J Segal; Y Kalechman
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

3.  Placental cytokine and chemokine production in HIV-1-infected women: trophoblast cells show a different pattern compared to cells from HIV-negative women.

Authors:  M Moussa; P Roques; N Fievet; E Menu; J G Maldonado-Estrada; J Brunerie; R Frydman; X Fritel; F Herve; G Chaouat
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

4.  Evaluation of Th17 and Treg cytokines in patients with unexplained recurrent pregnancy loss.

Authors:  Maral Farshchi; Elham Abdollahi; Nafiseh Saghafi; Ahmad Hosseini; Sara Fallahi; Sirus Rostami; Parifar Rostami; Houshang Rafatpanah; Mojtaba Habibagahi
Journal:  J Clin Transl Res       Date:  2022-05-25

Review 5.  Angiogenesis in implantation.

Authors:  Donald S Torry; Jonathan Leavenworth; Miao Chang; Vatsala Maheshwari; Kathleen Groesch; Evan R Ball; Ronald J Torry
Journal:  J Assist Reprod Genet       Date:  2007-07       Impact factor: 3.412

Review 6.  Cytokines: Important for implantation?

Authors:  Gérard Chaouat; Sylvie Dubanchet; Nathalie Ledée
Journal:  J Assist Reprod Genet       Date:  2007-11-28       Impact factor: 3.412

7.  A functional role of LEFTY during progesterone therapy for endometrial carcinoma.

Authors:  Wu Fei; Daiki Kijima; Mami Hashimoto; Miki Hashimura; Yasuko Oguri; Sabine Kajita; Toshihide Matsumoto; Ako Yokoi; Makoto Saegusa
Journal:  Cell Commun Signal       Date:  2017-12-21       Impact factor: 5.712

8.  Effect of autologous platelet-rich plasma for treatment of recurrent pregnancy loss: a randomized controlled trial.

Authors:  Leila Nazari; Saghar Salehpour; Sedighe Hosseini; Teibeh Hashemi; Nasrin Borumandnia; Elham Azizi
Journal:  Obstet Gynecol Sci       Date:  2022-03-28

9.  Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells.

Authors:  Xiaoping Luo; Jingxia Xu; Nasser Chegini
Journal:  Reprod Biol Endocrinol       Date:  2003-12-16       Impact factor: 5.211

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.